Aurora and Curaleaf Trade Barbs as Hostile Bid Deadline Approaches
Curaleaf and Aurora continued trading criticism as Curaleaf’s about $272 million bid remained open and is set to expire Dec. 1. Curaleaf CEO Boris Jordan said Aurora never signed an NDA, discussed no price, and made no counteroffer, while Curaleaf urged shareholders to focus on value. Curaleaf said its $5 cap and 105-day window are negotiable if Aurora’s board engages.